Original Article. Study of the cytotoxic/toxic potential of the novel anticancer selenodiazoloquinolone on fibroblast cells and 3D skin model

Open access

Abstract

The new synthetically prepared quinolone derivative 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo [3,4-h]quinoline-7-carboxylate (E2h) showed in our previous study cytotoxic effects towards tumor cells and immunomodulatory activities on RAW 264.7 cell line murine macrophages. E2h may have a potential use as a novel chemotherapeutic agent with immunomodulatory properties and the ability to induce apoptotic death of cancer cells. The aim of the present study was to examine the antiproliferative/cytotoxic activities of E2h on human non-cancer fibroblast BHNF-1 cells and reconstructed human epidermis EpiDerm™. Further the effects of E2h on tissue structure and morphology were examined. Cytotoxic/toxic studies showed that selenadiazoloquinolone is not toxic on normal human fibroblast cells BHNF-1 and dimensional skin constructs EpiDerm™. Evaluation of morphological changes in EpiDerm™ showed no change in the construction and morphology of skin tissue treated by E2h compared to control.

Adams M, Mahringer A, Kunert O, Fricker G, Efferth T, Bauer R. (2007). Cytotoxicity and p-glycoprotein modulating eff ects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa. Planta Med 73: 1554-1557.

Asoh K, Kohchi M, Hyoudoh I, Ohtsuka T, Masubuchi M, Kawasaki K, Ebiike H, Shiratori Y, Fukami T, Kondoh O, Tsukaguchi T, Ishii N, Aoki Y, Shimma N, Sakaitani M. (2009). Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors. Bioorg Med Chem Lett 19: 1753-1757.

Azema J, Guidetti B, Dewelle J, Le Calve B, Mijatovic T, Korolyov A, Vaysse J, Malet-Martino M, Martino R, Kiss R. (2009). 7-((4-Substituted)piperazin-1-yl) derivatives of ciprofl oxacin: Synthesis and in vitro biological evaluation as potential antitumor agents. Bioorg Med Chem 17: 5396-5407.

Barbieriková Z, Bella M, Lietava J, Dvoranová D, Staško A, Füzik T, Milata V, Jantová S, Brezová V. (2011a). Spectroscopic characterization and photoinduced processes of 4-oxoquinoline derivatives. J Photochem Photobiol A: Chemistry 224: 123-134.

Barbierikova Z, Bella M, Kučerák J, Milata V, Jantová S, Dvoranová D, Veselá M, Staško A, Brezová V. (2011b). Photoinduced Superoxide Radical Anion and Singlet Oxygen Generation in the Presence of Novel Selenadiazoloquinolones (An EPR Study). Photochem Photobiol 87: 32-44.

Barbieriková Z, Bella, M, Sekeráková Ľ, Lietava J, Bobeničová M, Dvoranová D, Milata V, Sádecká J, Mercheková D, Topoľská D, Heizer T, Hudec R, Czimerová A, Jantová S, Brezová V. (2013). Spectroscopic characterization, photoinduced processes and cytotoxic properties of substituted N-ethyl selenadiazoloquinolones. J Phys Org Chem 26: 565-574.

Bella M, Milata V. (2014). Synthesis of 9-ethyl[1,2,5]selenadiazolo[3,4-h]quinolones by the application of modifi ed Gould-Jacobs reaction to N-ethyl-2,1,3-benzoselenadiazol-4-amine. Arcivoc (v), 181-198.

Dalhoff A, (2005). Immunomodulatory activities of fl uoroquinolones. Infection 33: 55-70. Dalhoff A, Shalit I. (2003). Immunomodulatory eff ects of quinolones. Lancet Infect. Dis. 3: 359-371.

Darque A, Dumetre A, Hutter S, Casano G, Robin M, Pannecouque C, Azas N. (2009). Synthesis and biological evaluation of new heterocyclic quinolinones as anti-parasite and anti-HIV drug candidates. Bioorg Med Chem Lett 19: 5962-5964.

Drlica K, Zhao X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61: 377-392.

Drygin D, Siddiqui-Jain A, O’Brien S, Schwaebe M, Lin A, Bliesath J, Ho C, Proffi tt C, Trent K, Whitten J, Lim J, Von Hoff D, Anderes K, Rice W. (2009). Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res 69: 7653-7661.

Foroumadi A, Emami S, Rajabalian S, Badinloo M, Mohammadhosseini N, Shafiee A. (2009). N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study. Biomed Pharmacother 63: 216-220.

George S, Pili R. (2013). Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer. Curr Oncol Rep 15: 65-68.

Golub A, Yakovenko O, Bdzhola V, Sapelkin V, Zien P, Yarmoluk S. (2006). Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2. J Med Chem 49: 6443-6450.

Hadjeri M, Peiller E, Beney C, Deka N, Lawson M, Dumontet C, Boumendjel A, (2004). Antimitotic activity of 5-hydroxy-7-methoxy-2-phenyl-4-quinolones. J Med Chem 47: 4964-4970.

Huang L, Hsieh M, Teng C, Lee K, Kuo S. (1998). Synthesis and antiplatelet activity of phenyl quinolones. Bioorg Med Chem 6: 1657-1662.

Chang Y, Yang J, Kuo S, Chung J. (2009). Induction of mitotic arrest and apoptosis by a novel synthetic quinolone analogue, CWC-8, via intrinsic and extrinsic apoptotic pathways in human osteogenic sarcoma U-2 OS cells. Anticancer Res 29: 3139-3148.

Chou L., Yang J, Huang L, Wu H, Lu C, Chiang J, Chen K, Kuo S, Chung J. (2009). The synthesized 2-(2-fl uorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells. J Gastroenterol 44: 1055-1063.

Chung DT, Tsai CY, Chen SJ, Chang LW, King CHR, Hsu CH, Chiu KM, Tan HC, Chang YT, Hsu MC. (2010). Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers. Antimicrobiol Agents Chemother 54: 411-417.

Jantová S, Letašiová S, Koňariková K, Milata V, Brezová V. (2010). Eff ect of new synthetically prepared quinolone ethyl-1,4-dihydro-8-nitro-4-oxoquinoline-3-carboxylate on human leukemia cell line HL-60 without/with presence of UVA irradiation. Acta Chimica Slovaca 3: 51-72.

Jantová S, Koňariková K, Letašiová S, Paulovičová E, Milata V, Brezová V. (2011). Photochemical and phototoxic properties of ethyl 1,4-dihydro-8- nitro-4-oxoquinoline-3-carboxylate, a new quinolone derivative. J Photochem Photobiol B - Biology 102: 77-91.

Jantová S, Mrvová N, Hudec R, Sedlák J, Pánik M, Milata V. (2016a) Pro-apoptotic eff ect of new quinolone 7- ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5] selenadiazolo[3,4-h]quinoline-7-carboxylate on cervical cancer cell line HeLa alone/with UVA irradiation. Toxicol in Vitro 33: 35-44.

Jantová S, Paulovičová E, Paulovičová L, Topoľská D, Pánik M, Milata V. (2016b) The eff ects of novel selenadiazoloquinolone derivative on cancer cell proliferation, apoptosis and immunomodulatory activities. Cell Biol Toxicol [Accepted in Press].

Khodursky A, Zechiedrich E, Cozzarelli N. (1995). Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Nat Acad Sci USA 92: 11801-11805.

Letašiová S, Jantová S, Čipák Ľ, Múčková M. (2006). Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett 239: 254-262.

Medeiros B, Landau H, Morrow M, Lockerbie R, Pitts T, Eckhardt S. (2007). The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates signifi cant cytotoxic synergism against human leukemia cell lines. Leukemia 21(4): 739-46.

Meyer E, Schwab F, Gastmeier P, Ruden H, Heininger A. (2007). Antifungal use in intensive care units. J Antimicrobiol Chemother 60: 619-624.

Oriel J. (1989). Use of quinolones in chlamydial infection. Rev Infect Dis 11: S1273-S1276.

Riesbeck K. (2002). Immunomodulating activity of quinolones: review. J Chemother 14: 3-12.

Santos F, Abreu P, Castro H, Paixão I, Cirne-Santos C, Giongo V, Barbosa J, Simonetti B, Garrido V, Bou-Habib D, Silva D, Batalha P, Temerozo J, Souza T, Nogueira C, Cunha A, Rodrigues C, Ferreira V, de Souza M. (2009). Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives. Bioorg Med Chem 17: 5476-5481.

Sharma PC, Jain A, Jain S. (2009). Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects. Acta Pol Pharm 66: 587-604.

Sheng Z, Cao X, Peng S, Wang C, Li Q, Wang Y, Liu M. (2008). Ofl oxacin induces apoptosis in microencapsulated juvenile rabbit chondrocytes by caspase-8-dependent mitochondrial pathway. Toxicol Appl Pharmacol 226: 119-127.

Sokolova G, Kunichan AD, Lazareva YV. (2009). Levofl oxacin (Tavanic) in complex therapy of tuberculosis. Antibiot Khimioter 54: 31-37.

Tawfik AF, Shoeb HA, Bishop SJ, Al-Shammary FJ, Shbl AM. (1990). Infl uence of new quinolones on normal immune capabilities. J Chemother 2: 300-3005.

Vinayaka AC, Sadashiva MP, Wu X, Biryukov SS, Stoute JA, Rangappa KS, Gowda DC. (2014). Facile synthesis of antimalarial odiazoloquinolone on fi - broblasts and skin model 1,2-disubstituted 4-quinolones from 1,3-bisarylmonothio-1,3-diketones. Org Biomol Chem 12: 8555-8561.

Xia Y, Yang Z, Xia P, Hackl T, Hamel E, Mauger A, Wu J, Lee K. (2001). Antitumoragents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents. J Med Chem 44: 3932-3936.

Xiao ZP, Li HQ, Shi L, Lv PC, Song ZC, Zhu HL. (2008). Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4- ones. Chem Med Chem 3: 1077-1082.

Yamashita Y, Ashizawa T, Morimoto M, Hosomi J, Nakano H. (1992). Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity. Cancer Res 52: 2818-2822.

You Q, Li Z, Huang C, Yang Q, Wang X, Guo Q, Chen X, He X, Li T, Chern J. (2009). Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by Scaff old modifi cation. J Med Chem 52: 5649-5661.

Interdisciplinary Toxicology

The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences

Journal Information


CiteScore 2018: 1.78

SCImago Journal Rank (SJR) 2018: 0.274
Source Normalized Impact per Paper (SNIP) 2018: 0.671

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 254 163 8
PDF Downloads 120 98 5